BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 17459620)

  • 1. Chitosan/cyclodextrin nanoparticles as macromolecular drug delivery system.
    Krauland AH; Alonso MJ
    Int J Pharm; 2007 Aug; 340(1-2):134-42. PubMed ID: 17459620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effective protection and controlled release of insulin by cationic beta-cyclodextrin polymers from alginate/chitosan nanoparticles.
    Zhang N; Li J; Jiang W; Ren C; Li J; Xin J; Li K
    Int J Pharm; 2010 Jun; 393(1-2):212-8. PubMed ID: 20394813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mathematical modelling of the transport of hydroxypropyl-β-cyclodextrin inclusion complexes of ranitidine hydrochloride and furosemide loaded chitosan nanoparticles across a Caco-2 cell monolayer.
    Sadighi A; Ostad SN; Rezayat SM; Foroutan M; Faramarzi MA; Dorkoosh FA
    Int J Pharm; 2012 Jan; 422(1-2):479-88. PubMed ID: 22101294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probing insulin's secondary structure after entrapment into alginate/chitosan nanoparticles.
    Sarmento B; Ferreira DC; Jorgensen L; van de Weert M
    Eur J Pharm Biopharm; 2007 Jan; 65(1):10-7. PubMed ID: 17101268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chitosan-hyaluronic acid nanoparticles loaded with heparin for the treatment of asthma.
    Oyarzun-Ampuero FA; Brea J; Loza MI; Torres D; Alonso MJ
    Int J Pharm; 2009 Nov; 381(2):122-9. PubMed ID: 19467809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chitosan-graft-β-cyclodextrin nanoparticles as a carrier for controlled drug release.
    Yuan Z; Ye Y; Gao F; Yuan H; Lan M; Lou K; Wang W
    Int J Pharm; 2013 Mar; 446(1-2):191-8. PubMed ID: 23422276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chitosan/sulfobutylether-β-cyclodextrin nanoparticles as a potential approach for ocular drug delivery.
    Mahmoud AA; El-Feky GS; Kamel R; Awad GE
    Int J Pharm; 2011 Jul; 413(1-2):229-36. PubMed ID: 21540097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of surface charge, particle size and morphological properties of chitosan-TPP nanoparticles intended for gene delivery.
    Gan Q; Wang T; Cochrane C; McCarron P
    Colloids Surf B Biointerfaces; 2005 Aug; 44(2-3):65-73. PubMed ID: 16024239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimization of fabrication parameters to produce chitosan-tripolyphosphate nanoparticles for delivery of tea catechins.
    Hu B; Pan C; Sun Y; Hou Z; Ye H; Zeng X
    J Agric Food Chem; 2008 Aug; 56(16):7451-8. PubMed ID: 18627163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-ion-crosslinked nanoparticles with pH-responsive characteristics for oral delivery of protein drugs.
    Lin YH; Sonaje K; Lin KM; Juang JH; Mi FL; Yang HW; Sung HW
    J Control Release; 2008 Dec; 132(2):141-9. PubMed ID: 18817821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microspheres containing lipid/chitosan nanoparticles complexes for pulmonary delivery of therapeutic proteins.
    Grenha A; Remuñán-López C; Carvalho EL; Seijo B
    Eur J Pharm Biopharm; 2008 May; 69(1):83-93. PubMed ID: 18166446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and evaluation of warfarin-β-cyclodextrin loaded chitosan nanoparticles for transdermal delivery.
    Khalil SK; El-Feky GS; El-Banna ST; Khalil WA
    Carbohydr Polym; 2012 Oct; 90(3):1244-53. PubMed ID: 22939337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydroxypropyl chitosan bearing beta-cyclodextrin cavities: synthesis and slow release of its inclusion complex with a model hydrophobic drug.
    Prabaharan M; Mano JF
    Macromol Biosci; 2005 Oct; 5(10):965-73. PubMed ID: 16208630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monodisperse chitosan nanoparticles for mucosal drug delivery.
    Zhang H; Oh M; Allen C; Kumacheva E
    Biomacromolecules; 2004; 5(6):2461-8. PubMed ID: 15530064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New generation of hybrid poly/oligosaccharide nanoparticles as carriers for the nasal delivery of macromolecules.
    Teijeiro-Osorio D; Remuñán-López C; Alonso MJ
    Biomacromolecules; 2009 Feb; 10(2):243-9. PubMed ID: 19117404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclodextrin-insulin complex encapsulated polymethacrylic acid based nanoparticles for oral insulin delivery.
    Sajeesh S; Sharma CP
    Int J Pharm; 2006 Nov; 325(1-2):147-54. PubMed ID: 16859846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. pH-sensitive polyelectrolyte complex gel microspheres composed of chitosan/sodium tripolyphosphate/dextran sulfate: swelling kinetics and drug delivery properties.
    Lin WC; Yu DG; Yang MC
    Colloids Surf B Biointerfaces; 2005 Aug; 44(2-3):143-51. PubMed ID: 16054345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation and modification of N-trimethyl chitosan chloride nanoparticles as protein carriers.
    Chen F; Zhang ZR; Huang Y
    Int J Pharm; 2007 May; 336(1):166-73. PubMed ID: 17145144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ionically crosslinked chitosan/tripolyphosphate nanoparticles for oligonucleotide and plasmid DNA delivery.
    Csaba N; Köping-Höggård M; Alonso MJ
    Int J Pharm; 2009 Dec; 382(1-2):205-14. PubMed ID: 19660537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chitosan nanoconstructs for improved oral delivery of low molecular weight heparin: In vitro and in vivo evaluation.
    Paliwal R; Paliwal SR; Agrawal GP; Vyas SP
    Int J Pharm; 2012 Jan; 422(1-2):179-84. PubMed ID: 22079712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.